#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Glycogen storage disease type V Erdheim-Chester disease Laryngeal squamous cell carcinoma Acute hepatic failure Ductal adenocarcinoma of pancreas Splenic marginal zone lymphoma Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndrome Immune-mediated myasthenia gravis Hereditary motor and sensory neuropathy Non-small cell lung cancer metastatic Thromboangiitis obliterans ABO haemolytic disease of newborn Familial haemophagocytic lymphohistiocytosis Polymyositis Astrocytoma More trials…

    Learn about Rare Diseases

    Breast angiosarcoma metastatic Osteosarcoma Pemphigus – Treatment Mantle cell lymphoma refractory Mantle cell lymphoma Acquired haemophilia – Basic Information Noonan syndrome – Life with Disease Mantle cell lymphoma stage IV Immunodeficiency congenital – Basic Information Methylmalonic acidaemia – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Adct-402 Indometacin Afimetoran Besilate Dihydrate Pf-06480605 Trazodone ZOREVUNERSEN SODIUM Hmb-001 Nilutamide Varenicline Arachis Hypogaea (762) Axatilimab Gtaexs617 Terlipressin Bi 765845 Bt-001 Acetylsalicylic Acid Ph. Eur. CANNABINOL GXV813 Radiprodil CILOSTAZOL More therapies…

    Learn about Your Condition

    Hypotension Metastases to liver Cleft lip and palate Childhood asthma Atopic keratoconjunctivitis Influenza Myxoid liposarcoma Restless legs syndrome Optic ischaemic neuropathy Aortic valve disease Postpartum haemorrhage Autoimmune disorder Urethral stenosis Pouchitis Gaucher's disease type III More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. NZOZ Neuro- Kard Ilkowski i Partnerzy Spółka Partnerska…

NZOZ Neuro- Kard Ilkowski i Partnerzy Spółka Partnerska Lekarzy

Ul. Wierzbowa 2/2, Poznan, 61-853, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Medical Cannabis Aerosol for Treating Diabetic Nerve Pain in Patients Using Syqe Inhaler

    Not recruiting

    2 1
    Investigated Drugs:
    • Cannabis Sativa Flower
    Czechia Germany Poland

  • Study on Long-Term Safety and Effectiveness of Zilucoplan in Adults with Generalized Myasthenia Gravis

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • ZILUCOPLAN
    Italy Norway Poland Spain

  • Study Comparing Retatrutide and Tirzepatide for Weight Loss in Adults with Obesity

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Ly3437943 Sodium
    • Tirzepatide
    Germany Poland

  • Study on Donanemab, Florbetapir, and Flortaucipir for Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Donanemab
    • Florbetapir (18F)
    • Flortaucipir (18F)
    Czechia The Netherlands Poland

  • Study on the Effects of Vidofludimus Calcium in Adults with Relapsing Multiple Sclerosis

    Not recruiting

    3 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Vidofludimus Calcium
    Estonia Germany Poland Romania

  • Study on the Effects of Semaglutide in Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study of LY3556050 for Adults with Diabetic Peripheral Neuropathy Pain

    Not recruiting

    2 1
    Investigated Diseases:
    • Diabetic neuropathy
    Investigated Drugs:
    • Ly3556050
    Czechia Poland

  • Study on Ublituximab and Drug Combination for Patients with Myasthenia Gravis or Relapsing Multiple Sclerosis

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Myasthenia gravis
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Cetirizine
    • Ublituximab
    • Dexamethasone
    Poland

  • Study of LY3541860 and Meglumine Gadoterate for Adults with Relapsing Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Relapsing multiple sclerosis
    Investigated Drugs:
    • Ly3541860
    • Meglumine Gadoterate
    France Germany Italy Latvia Lithuania Poland +1

  • Study on the Effectiveness and Safety of AVP-786 (Quinidine Sulfate and Deudextromethorphan Hydrobromide) for Treating Agitation in Alzheimer’s Dementia Patients

    Not recruiting

    3 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Deudextromethorphan Hydrobromide
    • Quinidine Sulfate
    Bulgaria Denmark Estonia Germany Greece Poland +1
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!